MicroRNA-34a is dispensable for p53 function as teratogenesis inducer

被引:0
|
作者
Eyal Mor
Lin He
Arkady Torchinsky
Noam Shomron
机构
[1] Tel-Aviv University,Sackler Faculty of Medicine
[2] University of California at Berkeley,Division of Cellular and Developmental Biology, Molecular and Cell Biology Department
来源
Archives of Toxicology | 2014年 / 88卷
关键词
miRNA; microRNA; miR-34; Limbs; Development; p53; Teratogens;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor suppressor protein p53 is a powerful regulator of the embryo’s susceptibility to diverse teratogenic stimuli, functioning both as a teratogenesis inducer and suppressor. However, the targets that p53 engages to fulfill its functions remain largely undefined. We asked whether the microRNA (miRNA) miR-34 family, identified as one of the main targets of p53, mediates its function as a teratogenesis inducer. For this, pregnant ICR-, p53- and miR-34a-deficient mice, as well as rats, were exposed to 5-aza-2′-deoxycytidine (5-aza), a teratogen inducing limb reduction anomalies (LRA) of the hindlimbs in mice and either the hindlimbs or forelimbs in rats. Using hind- and forelimb buds of 5-aza-exposed embryos, we identified that the miR-34 family members are the most upregulated miRNAs in mouse and rat limb buds, with their increase level being significantly higher in limb buds destined for LRA. We showed that p53 mediates the 5-aza-induced miR-34 transcription followed by met proto-oncogene and growth-arrest-specific 1 target suppression in embryonic limb buds. We demonstrated that p53 regulates the teratogenic response to 5-aza acting as a teratogenesis inducer albeit miR-34a deletion does not affect the susceptibility of mice to 5-aza. Overall, our study thoroughly characterizes the expression and regulation of miR-34 family in teratogen-resistant and teratogen-sensitive embryonic structures and discusses the involvement of epigenetic miRNA-mediated pathway(s) in induced teratogenesis.
引用
收藏
页码:1749 / 1763
页数:14
相关论文
共 50 条
  • [31] MiR-34a and p53
    Hermeking, Heiko
    CELL CYCLE, 2009, 8 (09) : 1308 - 1308
  • [32] Differential MicroRNA-34a Expression and Tumor Suppressor Function in Retinoblastoma Cells
    Dalgard, Clifton L.
    Gonzalez, Marco
    deNiro, Jennifer E.
    O'Brien, Joan M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (10) : 4542 - 4551
  • [33] MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251
    Luan, Shihai
    Sun, Linlin
    Huang, Fengping
    ARCHIVES OF MEDICAL RESEARCH, 2010, 41 (02) : 67 - 74
  • [34] MicroRNA-1.99a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells
    Tian, Ye
    Zhang, Ying-Ze
    Chen, Wei
    BIOSCIENCE REPORTS, 2014, 34 : 479 - 485
  • [35] P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy
    Ding-Guo Zhang
    Jun-Nian Zheng
    Dong-Sheng Pei
    Molecular Cancer, 13
  • [36] Dynamic Behavior of p53 Driven by Delay and a Microrna-34a-Mediated Feedback Loop
    Gao, Chunyan
    Liu, Haihong
    Yan, Fang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [37] P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy
    Zhang, Ding-Guo
    Zheng, Jun-Nian
    Pei, Dong-Sheng
    MOLECULAR CANCER, 2014, 13
  • [38] P53 FUNCTION AND DYSFUNCTION
    VOGELSTEIN, B
    KINZLER, KW
    CELL, 1992, 70 (04) : 523 - 526
  • [39] Speckle function for p53
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2021, 22 : 372 - 372
  • [40] 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation
    M K Dijkstra
    K van Lom
    D Tielemans
    F Elstrodt
    A W Langerak
    M B van ‘t Veer
    M Jongen-Lavrencic
    Leukemia, 2009, 23 : 625 - 627